Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BLND NASDAQ:EVER NASDAQ:GDYN NASDAQ:HCAT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLNDBlend Labs$3.62+0.3%$3.48$2.37▼$5.53$937.38M1.241.72 million shs1.48 million shsEVEREverQuote$25.71-0.6%$24.39$16.63▼$30.03$924M0.34345,187 shs614,016 shsGDYNGrid Dynamics$10.46+0.8%$11.86$10.26▼$25.50$877.60M1.04725,020 shs1.00 million shsHCATHealth Catalyst$3.88+0.8%$3.86$3.49▼$9.24$267.96M1.51524,421 shs554,639 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLNDBlend Labs-0.06%+2.50%+7.98%+9.15%+23.31%EVEREverQuote+0.47%+4.74%+7.35%+10.65%+4.78%GDYNGrid Dynamics-3.80%-2.99%-12.18%-25.64%-13.43%HCATHealth Catalyst-4.94%+2.67%+2.94%-6.10%-49.48%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLNDBlend Labs3.3321 of 5 stars3.43.00.00.03.23.30.6EVEREverQuote3.9497 of 5 stars3.62.00.00.03.44.21.9GDYNGrid Dynamics2.5753 of 5 stars3.61.00.00.04.22.50.0HCATHealth Catalyst3.8915 of 5 stars3.31.00.03.81.52.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLNDBlend Labs 2.89Moderate Buy$4.9035.28% UpsideEVEREverQuote 3.17Buy$32.5026.41% UpsideGDYNGrid Dynamics 3.20Buy$18.7579.25% UpsideHCATHealth Catalyst 2.58Moderate Buy$8.00106.19% UpsideCurrent Analyst Ratings BreakdownLatest HCAT, GDYN, EVER, and BLND Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/9/2025HCATHealth CatalystEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetIn-Line ➝ In-Line$5.00 ➝ $4.006/17/2025HCATHealth CatalystBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral5/28/2025BLNDBlend LabsJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$7.005/19/2025BLNDBlend LabsKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Perform ➝ Market Perform$3.50 ➝ $4.005/12/2025BLNDBlend LabsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$5.60 ➝ $4.805/12/2025BLNDBlend LabsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$5.25 ➝ $5.255/8/2025HCATHealth CatalystCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$10.00 ➝ $9.005/8/2025HCATHealth CatalystStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$5.00 ➝ $5.505/6/2025EVEREverQuoteJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $30.005/6/2025EVEREverQuoteNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$38.00 ➝ $38.005/2/2025GDYNGrid DynamicsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$18.00 ➝ $20.00(Data available from 7/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLNDBlend Labs$162.02M5.80N/AN/A($0.22) per share-16.46EVEREverQuote$500.19M1.84$1.06 per share24.36$3.80 per share6.77GDYNGrid Dynamics$350.57M2.52$0.35 per share29.96$6.19 per share1.69HCATHealth Catalyst$306.58M0.88$0.36 per share10.92$6.00 per share0.65Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLNDBlend Labs-$43.35M-$0.20N/AN/AN/A-22.72%N/A-13.37%8/7/2025 (Confirmed)EVEREverQuote$32.17M$1.0225.2131.74N/A6.64%35.40%22.81%8/4/2025 (Estimated)GDYNGrid Dynamics$4.04M$0.1287.17∞N/A2.94%1.37%1.19%7/31/2025 (Estimated)HCATHealth Catalyst-$69.50M-$1.15N/AN/AN/A-23.34%-6.14%-2.74%8/7/2025 (Estimated)Latest HCAT, GDYN, EVER, and BLND EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025BLNDBlend Labs$0.02N/AN/AN/A$31.93 millionN/A8/7/2025Q2 2025HCATHealth Catalyst$0.05N/AN/AN/A$80.59 millionN/A8/4/2025Q2 2025EVEREverQuote$0.33N/AN/AN/A$157.19 millionN/A7/31/2025Q2 2025GDYNGrid Dynamics$0.09N/AN/AN/A$100.45 millionN/A5/1/2025Q1 2025GDYNGrid Dynamics$0.09$0.11+$0.02$0.03$98.19 million$100.42 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLNDBlend LabsN/AN/AN/AN/AN/AEVEREverQuoteN/AN/AN/AN/AN/AGDYNGrid DynamicsN/AN/AN/AN/AN/AHCATHealth CatalystN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLNDBlend LabsN/A2.412.41EVEREverQuoteN/A2.422.42GDYNGrid DynamicsN/A7.257.25HCATHealth Catalyst0.401.241.24Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLNDBlend Labs52.56%EVEREverQuote91.54%GDYNGrid Dynamics71.18%HCATHealth Catalyst85.00%Insider OwnershipCompanyInsider OwnershipBLNDBlend Labs35.52%EVEREverQuote29.79%GDYNGrid Dynamics7.20%HCATHealth Catalyst2.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLNDBlend Labs1,690259.66 million167.43 millionNot OptionableEVEREverQuote61035.72 million25.08 millionOptionableGDYNGrid Dynamics4,73084.55 million78.46 millionOptionableHCATHealth Catalyst1,50069.60 million67.79 millionOptionableHCAT, GDYN, EVER, and BLND HeadlinesRecent News About These CompaniesPatrick NelliJuly 24 at 2:27 PM | benefitnews.comBHealth Catalyst, Inc. (HCAT) Stock Competitors & Similar Stocks ...July 23 at 10:42 AM | seekingalpha.comAMH Equity Ltd Takes $1.14 Million Position in Health Catalyst, Inc. (NASDAQ:HCAT)July 19, 2025 | marketbeat.com3 Unprofitable Stocks We Approach with CautionJuly 18, 2025 | finance.yahoo.comHealth Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025July 17, 2025 | globenewswire.com6HCAT : Deep Dive Into Health Catalyst Stock: Analyst Perspectives (5...July 9, 2025 | benzinga.comEvercore ISI Cuts Health Catalyst (NASDAQ:HCAT) Price Target to $4.00July 9, 2025 | marketbeat.comHealth Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Moderate Buy" by AnalystsJuly 8, 2025 | marketbeat.comHCAT - Health Catalyst Inc Key Metrics - MorningstarJuly 4, 2025 | morningstar.comMAccelerating Measurable Improvement Through Actionable Insights: Health Catalyst Announces the Release of 10 AI-Integrated Data Toolkits on Databricks MarketplaceJuly 1, 2025 | prnewswire.comHealth Catalyst, Inc. (HCAT) Income Statement - Yahoo FinanceJune 26, 2025 | finance.yahoo.comHealth Catalyst (HCAT) Upgraded to Buy: Here's WhyJune 19, 2025 | zacks.comHealth Catalyst (NASDAQ:HCAT) shareholders have endured a 88% loss from investing in the stock five years agoJune 19, 2025 | finance.yahoo.comData Analytics Stocks Q1 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The RestJune 17, 2025 | msn.comHCAT Q1 Earnings Call: Ignite Platform Drives Client Growth Amid Funding UncertaintyJune 12, 2025 | msn.comHealth Catalyst: Ignite Platform Is A Growth CatalystJune 10, 2025 | seekingalpha.comHealth Catalyst, Inc. (NASDAQ:HCAT) General Counsel Benjamin Landry Sells 6,057 SharesJune 10, 2025 | insidertrades.com3 Stocks Under $10 with Questionable FundamentalsMay 20, 2025 | msn.comHealth Catalyst to Participate in Upcoming Investor ConferencesMay 20, 2025 | globenewswire.comWhy Health Catalyst, Inc.’s (HCAT) Stock Is Down 5.02%May 16, 2025 | aaii.comA1 Mooning Stock Worth Your Attention and 2 to AvoidMay 12, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy Centene Stock Dropped 40% — And Whether It's a Buy NowBy Leo Miller | July 8, 2025View Why Centene Stock Dropped 40% — And Whether It's a Buy NowD-Wave Rises 12% in 1 Day, Beating Rivals: What Caused the Spike?By Nathan Reiff | July 22, 2025View D-Wave Rises 12% in 1 Day, Beating Rivals: What Caused the Spike?Broadcom Stock: HSBC Sets $400 Target on AI Growth PotentialBy Leo Miller | July 11, 2025View Broadcom Stock: HSBC Sets $400 Target on AI Growth PotentialBuffett's $2B+ Bet With Big Long-Term Potential Just Got UpgradedBy Leo Miller | July 10, 2025View Buffett's $2B+ Bet With Big Long-Term Potential Just Got UpgradedCongress Is Dumping These 5 Stocks—Should You Follow?By Thomas Hughes | July 25, 2025View Congress Is Dumping These 5 Stocks—Should You Follow?HCAT, GDYN, EVER, and BLND Company DescriptionsBlend Labs NYSE:BLND$3.62 +0.01 (+0.33%) Closing price 03:59 PM EasternExtended Trading$3.61 -0.01 (-0.33%) As of 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Blend Labs, Inc. engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty. It also offers verification components to automate confirmation tasks that are needed to underwrite a loan or approve the opening of a new deposit account; decisioning components to reduce the need for human intervention by automatically applying business rules throughout an application workflow configured by a financial services firm; workflow intelligence components to manage data collection and automate tasks throughout the loan origination process; and marketplace components to enable consumers to shop for products and services presented at the precise moment of need during an application for a loan. In addition, the company, through its subsidiary, offers title search procedures for title insurance policies, escrow, and other closing and settlement services, as well as other trustee services; and provides professional and consulting services. It serves banks, credit unions, fintechs, and non-bank mortgage lenders. The company was incorporated in 2012 and is headquartered in San Francisco, California.EverQuote NASDAQ:EVER$25.71 -0.15 (-0.58%) Closing price 04:00 PM EasternExtended Trading$26.61 +0.90 (+3.50%) As of 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.EverQuote, Inc. operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc., and changed its name to EverQuote, Inc. in November 2014. EverQuote, Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.Grid Dynamics NASDAQ:GDYN$10.46 +0.08 (+0.77%) Closing price 04:00 PM EasternExtended Trading$10.46 0.00 (0.00%) As of 06:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Grid Dynamics Holdings, Inc., together with its subsidiaries, provides technology consulting, platform and product engineering, and analytics services in North America, Europe, and internationally. It offers cloud platform and product engineering services, such as architecting, designing, and building scalable and secure cloud-based platforms and business applications; and AI/machine learning and data platform engineering services that build platforms to facilitate batch and streaming data ingestion, quality governance, orchestration, semantic modeling, observability, and analysis at scale. The company provides digital engagement services, including digital ecosystem design and implementation; and supply chain, Internet of Thing, and advanced manufacturing, which focuses on transforming traditional operations into smart and connected ecosystems. It serves customers that operate in the tech, media, telecommunications, retail, consumer packaged goods, manufacturing, and finance industries. The company was formerly known as ChaSerg Technology Acquisition Corp. and changed its name to Grid Dynamics Holdings, Inc. Grid Dynamics Holdings, Inc. was founded in 2006 and is headquartered in San Ramon, California.Health Catalyst NASDAQ:HCAT$3.88 +0.03 (+0.78%) Closing price 04:00 PM EasternExtended Trading$3.82 -0.06 (-1.55%) As of 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Intel's Turnaround Gains Credibility With Strong Q2 Report Qualcomm's Next Gear: A Growth Story Wall Street Might Be Missing Krispy Kreme: A Meme Stock Sugar Rush or a Sustainable Treat? From Zero to Hero? Why GoPro's Rally Could Be More Than It Seems CrowdStrike Scores Big With Gartner, But Valuation Is Stretched ServiceNow: The 2nd Wave of AI Spending Is Here Tractor Supply Revs Up on Forecast Hike and Bullish Signals A Smokin’ Hot Entry Point for Chipotle Stock Opens in Q3 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
